FDA
-
-
-
-
-
-
-
ORIC Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Update
-
-
-
-
-
-
-
ORIC Pharmaceuticals Presents Data Supporting the Therapeutic Potential of ORIC-533 in Multiple Myeloma at the American Society of Hematology (ASH) Annual Meeting
-
-
-
-
-
-
-
ORIC Pharmaceuticals Reports Second Quarter 2021 Financial Results and Operational Update
-
-
-
-
-
-
-
ORIC Pharmaceuticals (ORIC) Provides Corporate Update and Highlights Key 2021 Milestones
-
-
-
-
-
-
-
ORIC Pharmaceuticals Reports Third Quarter 2020 Financial and Operational Update
-
-
-
-
-
-
-
ORIC Pharmaceuticals Reports First Quarter 2020 Financial and Operational Results
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

